$0.289
+0.003 (+1.01%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GTBP Prediction & Forecast by Similar Chart Analysis
Alphio's GTBP stock price prediction model matches the current GT Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.29 (-1.25%). The 1-week path is $0.29 (-0.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy GT Biopharma Inc Stock?
GT Biopharma Inc is currently not a strong buy due to its ongoing financial losses and declining stock performance, despite a recent positive trend. The stock closed at $0.30, with a year-to-date decline of 63.28%. The RSI is at 53.044, indicating a neutral momentum, while the forward P/E ratio is 17.331, suggesting potential for future earnings but also a risk given the company’s current losses. The main risk is the significant net loss of $28.4 million reported for FY2025, which raises concerns about profitability and investor confidence.
GTBP stock price ended at $0.29 on Tuesday, after rising +1.01%
GT Biopharma Inc (GTBP) last closed at $0.2889, gaining +1.01%. These facts feed the 1-day and 1-week GTBP price prediction above.
Forecast Drivers
GT Biopharma Inc (GTBP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GTBP, ranked by similarity.
Seasonality analysis for GTBP
Historically the probability of a positive September return for GTBP is 0.00%. June offers the highest probability of a positive month at 16.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GTBP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $2.42 | $2.49 | $2.64 | +761.01% |
| Oct 2026 | $2.21 | $2.25 | $2.32 | +678.93% |
| Nov 2026 | $1.97 | $2.17 | $2.56 | +652.64% |
| Dec 2026 | $2.03 | $2.26 | $2.28 | +683.07% |
In 2026, GT Biopharma Inc (GTBP) is projected to range from $1.97 to $2.64.
GT Biopharma Inc 2026 monthly forecast
In Sep 2026, GT Biopharma Inc is projected to average $2.49, with a low of $2.42 and high of $2.64.
In Oct 2026, GT Biopharma Inc is projected to average $2.25, with a low of $2.21 and high of $2.32.
In Nov 2026, GT Biopharma Inc is projected to average $2.17, with a low of $1.97 and high of $2.56.
In Dec 2026, GT Biopharma Inc is projected to average $2.26, with a low of $2.03 and high of $2.28.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.